HOYA Vision Care recently commissioned a consumer research study to test market messaging options with eye care patients. “Strategies for Keeping Purchases at Independent Practices: Prescribing for Blue Light Overexposure” is the title of the study results summary report released today that summarizes the research findings and offers independent ECPs easy to implement tactics.
The science behind HOYA’s product development is complex; however the benefits to patients are very concrete. HOYA’s customers, independent ECPs, need tools to simply share the environmental concerns we have in our society today and then prescribe a solution to their patients. People have very real, chronic symptoms brought on by over exposure to blue light and, together with the doctor, we can help them. The study HOYA conducted, results, and tools will help ECPs help their patients as well as build their individual brands.
Respondents in the study shared with HOYA:
1. They had either never heard of blue light or only associated it with sleep patterns, rather than eye
2. Acknowledged that blue light can cause macular degeneration, though such terms were viewed as
3. They would listen to their eye doctor’s recommendations with regard to blue light protection
4. News articles and medical studies helped validate the information they were presented
5. They are seeking good value – which doesn’t always mean lowest price
The results of the study are summarized in the report and go into details on how to utilize the exam as an opportunity to present the issue of blue light with patients. Practical tips, data points and life style questions are just some of the tools provided. In addition there is a section that outlines when offering HOYA lenses and treatments such as Sync and Recharge, the first AR treatment to offer blue light filtering, would be most beneficial.
Copies of “Strategies for Keeping Purchases at Independent Practices: Prescribing for Blue Light Overexposure” are available through your HOYA Territory Sales Manager.
Hoya Corporation is a global technology company traded on the Japanese stock exchange based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech and healthcare products based upon its advanced optics technologies. Hoya is active in four fields of business: The Healthcare provides eyeglasses and contact lenses for retail sales. The Medical provides endoscopic system and intraocular lenses for cataract surgery. The Electronics makes mask blanks and photo masks for the semiconductor devices and LCD panels as well as glass memory disks for HDDs. The Imaging produces optical lenses,SLR/compact digital cameras, lens modules and micro lenses. Hoya now has over 100 subsidiaries and affiliates, and employs over 36,500 people worldwide.
For more information visit www.hoya.ca.